These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 30067556

  • 21. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
    Wang H, Guo X, Duan Y, Zheng B, Gao Y.
    Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
    [Abstract] [Full Text] [Related]

  • 22. Sirolimus, a promising treatment for refractory Kaposiform hemangioendothelioma.
    Kai L, Wang Z, Yao W, Dong K, Xiao X.
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):471-6. PubMed ID: 24464150
    [Abstract] [Full Text] [Related]

  • 23. Kaposiform hemangioendothelioma: current knowledge and future perspectives.
    Ji Y, Chen S, Yang K, Xia C, Li L.
    Orphanet J Rare Dis; 2020 Feb 03; 15(1):39. PubMed ID: 32014025
    [Abstract] [Full Text] [Related]

  • 24. Management of Refractory Mandibular Kaposiform Hemangioendothelioma with Sirolimus: A Case Report and Review of the Literature.
    Rikhotso RE, Alharbi AA.
    J Oral Maxillofac Surg; 2021 Oct 03; 79(10):2086.e1-2086.e8. PubMed ID: 34153244
    [Abstract] [Full Text] [Related]

  • 25. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
    Mariani LG, Schmitt IR, Garcia CD, Kiszewski AE.
    Pediatr Blood Cancer; 2019 Aug 03; 66(8):e27810. PubMed ID: 31087627
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Interferon-alpha therapy for refractory kaposiform hemangioendothelioma: a single-center experience.
    Wu HW, Wang X, Zhang L, Zhao HG, Wang YA, Su LX, Fan XD, Zheng JW.
    Sci Rep; 2016 Oct 31; 6():36261. PubMed ID: 27796340
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A case of kaposiform haemangioendothelioma successfully and safely treated with sirolimus.
    Wlodek C, Burt H, Shaw L.
    Clin Exp Dermatol; 2017 Oct 31; 42(7):825-827. PubMed ID: 28703334
    [No Abstract] [Full Text] [Related]

  • 32. NEWBORNS WITH KASABACH-MERRITT PHENOMENON-ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: A REPORT OF 6 CASES.
    Benzar IM, Rebenkov SO, Levytskyi AF, Fedoniuk LY, Fomina LV, Sas LM, Stravskyy TY.
    Wiad Lek; 2020 Oct 31; 73(8):1785-1789. PubMed ID: 33055352
    [Abstract] [Full Text] [Related]

  • 33. Long-term outcome for kaposiform hemangioendothelioma: A report of two cases.
    Schaefer BA, Wang D, Merrow AC, Dickie BH, Adams DM.
    Pediatr Blood Cancer; 2017 Feb 31; 64(2):284-286. PubMed ID: 27701822
    [Abstract] [Full Text] [Related]

  • 34. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns.
    Garcia-Monaco R, Giachetti A, Peralta O, Napoli N, Lobos P, Gioseffi L, Mariani G.
    J Vasc Interv Radiol; 2012 Mar 31; 23(3):417-22. PubMed ID: 22365299
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effective low-dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon in young infants.
    Harbers VEM, van der Salm N, Pegge SAH, van der Vleuten CJM, Verhoeven BH, Vrancken SLAG, Schultze Kool LJ, Fuijkschot J, Te Loo DMMWM.
    Br J Clin Pharmacol; 2022 Jun 31; 88(6):2769-2781. PubMed ID: 34957601
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.
    Ji Y, Chen S, Zhou J, Yang K, Zhang X, Xiang B, Qiu T, Gong X, Zhang Z, Lan Y, Hu F, Kong F, Qiu Q, Zhang Y.
    Blood; 2022 Mar 17; 139(11):1619-1630. PubMed ID: 35030255
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.